ELECTRON-SPIN-RESONANCE ANALYSIS OF HEME-NITROSYL AND REDUCED IRON-SULFUR CENTERED COMPLEXES IN ALLOGENEIC, HETEROTOPIC CARDIAC TRANSPLANTS- EFFECTS OF TREATMENT WITH PYRROLIDINE DITHIOCARBAMATE

Citation
Al. Nakanishi et al., ELECTRON-SPIN-RESONANCE ANALYSIS OF HEME-NITROSYL AND REDUCED IRON-SULFUR CENTERED COMPLEXES IN ALLOGENEIC, HETEROTOPIC CARDIAC TRANSPLANTS- EFFECTS OF TREATMENT WITH PYRROLIDINE DITHIOCARBAMATE, Free radical biology & medicine, 25(2), 1998, pp. 201-207
Citations number
35
Categorie Soggetti
Endocrynology & Metabolism",Biology
ISSN journal
08915849
Volume
25
Issue
2
Year of publication
1998
Pages
201 - 207
Database
ISI
SICI code
0891-5849(1998)25:2<201:EAOHAR>2.0.ZU;2-V
Abstract
Inhibition of inducible nitric oxide synthase (iNOS) prolongs allograf t survival suggesting a role for nitric oxide ((NO)-N-.) in allograft rejection. Induction of iNOS is regulated by the oxidant-sensitive, nu clear factor kappa B (NF-KB) in many cell types. In the present study using electron spin resonance (ESR) spectroscopy, we evaluated whether pyrrolidine dithiocarbamate (PDTC), a metal chelator and antioxidant, might limit (NO)-N-. production during the development of rejection i n cardiac allografts. We performed either isogeneic (Lewis to Lewis) o r allogeneic (Wistar-Furth to Lewis) heterotopic abdominal cardiac tra nsplantation. Allograft recipients received daily injections of PDTC o r aminoguanidine (a known inhibitor of iNOS). At postoperative days 4, or 6, grafted and native hearts of transplant recipients were flushed with cardioplegic solution to remove blood contamination. ESR data of allografts revealed a triplet nitrogen signal (a(N) = 17.5 G) and cen tered at g = 2.012 and an additional broad signal at g = 2.08. This si gnal was not seen in either isografts or native hearts of either isogr aft or allograft recipients. Based upon these parameters, these signal s are attributed to nitrosomyoglobin. This signal was inhibited by tre atment with aminoguanidine or PDTC. Under these conditions, PDTC also prolonged graft survival from 6.6 +/- 0.2 to 11.7 +/- 0.3 days. Thus, it is conceivable that nitrosylmyoglobin formation precedes rejection in cardiac allografts and inhibition of nitrosomyoglobin with agents s uch as PDTC contribute to improved graft survival. (C) 1998 Elsevier S cience Inc.